Therapeutic uses of anti-interleukin-6 receptor antibody.
about
Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsBeneficial Effects of Anti-Interleukin-6 Antibodies on Impaired Gastrointestinal Motility, Inflammation and Increased Colonic Permeability in a Murine Model of Sepsis Are Most Pronounced When Administered in a Preventive SetupCD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaInterleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation.Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys.Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases.Use of polyclonal/monoclonal antibody therapies in transplantation.Ligand-inducible dimeric antibody for selecting antibodies against a membrane protein based on mammalian cell proliferation.Unintended Immunological Consequences of Biologic Therapy.Immunotherapeutic implications of IL-6 blockade for cytokine storm.Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery.Immunopathology alters Th17 cell glucocorticoid sensitivity.Pharmacological and immunological targeting of tumor mesenchymalization.Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature.IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections.Regulation of IL-6 in Immunity and Diseases.Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells.Puerarin Exerts an Antiinflammatory Effect by Inhibiting NF-kB and MAPK Activation in Staphylococcus aureus-Induced Mastitis.Pattern Recognition of the Multiple Sclerosis Syndrome.Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome.Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis.Treatment strategies for autoimmune encephalitis.Polymorphisms of immunoglobulin receptors and the effects on clinical outcome in cancer immunotherapy and other immune diseases: a general review.Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction.Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial.Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration.Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
P2860
Q26800158-AE4DF459-91BF-40BE-8FD8-13F4E4B21F3BQ27315053-5403D318-3638-47A2-BF50-70598B3B4EA8Q28084879-B010A8F1-01DA-4FBB-9A83-A635178A2546Q35439628-8520FC80-671C-4A61-942C-C27164FCAA45Q36579912-419191B0-05AA-43DE-9D79-525D29CE5B81Q38382090-DB6C3EE3-5EA0-479D-8C46-489617C42610Q38769922-61E18F43-3BB3-4446-9993-7F7962D8247CQ38826849-ED5B2CA1-2E10-478E-96D8-D7FB9FD9F5F2Q38871098-9D62113A-2BB2-45ED-981D-8CCA088F979BQ38887311-FC89E163-7873-4C94-8C84-E206AE6FB037Q38958166-674E67C2-05EF-4F84-B781-42A8262C9072Q38959155-38B41C90-5813-4B0B-AECF-E4F171489B4CQ39029043-9C7B55E5-E04A-4B08-8E9F-EC0AB345F71AQ39445471-0A1C0FDC-5882-40B1-857D-CD1BB626CFE5Q39815392-A8CB9C92-FEE7-4491-9320-79593D550936Q40508670-53628EC7-E915-493D-9C69-584038000286Q42013055-065DF4B3-A8E3-4BCC-9A44-A9D510EE2518Q44123813-987228B8-DF66-4302-B922-EA4C6E1313A0Q47096340-FE34D0BE-3305-4E16-BFAB-0C1E9C1F9937Q47909467-6C5AC810-C20A-4D68-BB3C-0FDEE274DD4EQ48022107-64C26147-A8E1-4E11-8064-106F8ED92615Q49213573-FAC2E9ED-80D7-4878-98FF-500D08F5A3EDQ50089138-07E130AA-ADCF-486F-901C-6669185B1F71Q50137412-8E0C146C-C971-4C6D-96D4-176DE3DEE8A0Q50700806-C74347FF-E9B1-4B12-A2C0-25BD577DE754Q53504304-D22819F9-536D-40BF-B7B6-B1543B720311Q55246388-CCBB2600-CAED-4BC2-9212-901217943577Q57116991-02218768-4D3B-4F3E-8987-86A4ACDE6D34
P2860
Therapeutic uses of anti-interleukin-6 receptor antibody.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Therapeutic uses of anti-interleukin-6 receptor antibody.
@en
type
label
Therapeutic uses of anti-interleukin-6 receptor antibody.
@en
prefLabel
Therapeutic uses of anti-interleukin-6 receptor antibody.
@en
P2093
P2860
P356
P1476
Therapeutic uses of anti-interleukin-6 receptor antibody.
@en
P2093
Sujin Kang
Tadamitsu Kishimoto
Toshio Tanaka
P2860
P356
10.1093/INTIMM/DXU081
P577
2014-08-20T00:00:00Z